People with pulmonary arterial hypertension and their physicians hardly ever agree on the severity of symptoms, a study shows ...

Patients with pulmonary arterial hypertension and cardiovascular comorbidities may benefit from the use of inhaled or oral ...

Investors seemed to panic after the announcement, with a sell-off driving Keros' share price down 73%, reversing strong gains ...

The Mini Nutritional Assessment was viable for assessing nutritional status and predicting mortality outcomes in patients ...

Merck’s new pulmonary arterial hypertension (PAH) medication has posted another batch of promising clinical trial data, ...

Most patients with pulmonary arterial hypertension (PAH) suffered from poor sleep quality, and dyspnea was a significant predictor of sleep quality, independent of disease severity, according to ...

A recent systematic review assessed the psychometric properties of various instruments for measuring QOL in patients with ...

The connection between PAH and blood sugar may be conveyed through pulmonary vascular remodeling, showing SHR as an indicator ...

ZENITH was stopped early due to strong efficacy data showing reduced mortality and morbidity event risk with sotatercept. Topline interim results were announced from a phase 3 trial evaluating ...

Living with Pulmonary Arterial Hypertension (PAH) affects not only patients but also the caregivers who support them, facing ...

We are focused on chronic obstructive pulmonary disease (COPD), pulmonary arterial hypertension (PAH), interstitial lung ...